Lilly shares rose more than 4% Monday, while rival Novo Nordisk tanked.
Get this delivered to your inbox, and more info about our products and services.
Club holding Lilly stock slumped 1% Tuesday while Novo Nordisk shares jumped nearly 9%.
Club name Eli Lilly made its third deal of the year to acquire an attractive experimental drug.
Eli Lilly's stock is soaring while Novo Nordisk is sinking. Why it makes sense to stick with the market winner, despite its…
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Thanks to its “best-in-class” status, the bank believes the company will be the winner from a growing GLP-1 patient base.
The split in outlook underscores Lilly's strong position in the obesity market, underpinned by more effective drugs and its…
